Opportunities / HEALTH AND HUMAN SERVICES, DEPARTMENT OF

FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Notice typeSpecial Notice
Solicitation #FDABAA-27-00123
DepartmentHEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier / officeFOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAJ11
Set-asideNo set-aside
PostedOct 30, 2026
Response deadlineFeb 1, 2027 (2027-02-01T17:00:00-05:00)
Place of performance—
Primary contactIan Weiss · Ian.Weiss@fda.hhs.gov · 3017965728

Description (excerpt)

In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.

View the official notice on SAM.gov →